Search results
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Novavax sinks on concerns about COVID vaccine maker's prospects
Reuters via Yahoo News· 1 year agoNovavax Inc's shares plunged to a three-year low on Wednesday, a day after the COVID-19 vaccine...
New COVID-19 vaccine Novavax offers alternative option in El Paso
The El Paso Times via Yahoo News· 7 months agoThe U.S. Food and Drug Administration approved the updated Novavax vaccine on Tuesday, allowing a...
Novavax COVID shot, aimed at vaccine skeptics, overwhelmingly backed by FDA panel
Reuters via Yahoo News· 2 years ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Tuesday voted overwhelmingly to...
Novavax has its sights set on the commercial COVID-19 vaccine market
Yahoo Finance· 2 years agoNovavax isn't swayed by the negative perceptions and delays in reaching the. market in the U.S., and...
When will Novavax's vaccine be available, and how can I get it?
CBS News via Yahoo News· 2 years agoThe Biden administration is warning states to prepare for a "limited supply" of Novavax's COVID-19...
FDA Advisory Committee Recommends Novavax COVID-19 Vaccine for Use in the U.S.
GOBankingRates via Yahoo Finance· 2 years agoAmericans could have access to a new COVID-19 vaccine as early as this week after a panel of Food...
Novavax Crashes As Alternative To Pfizer, Moderna Covid Shots Lags Estimates
Investor's Business Daily· 2 years agoNovavax reported lighter-than-expected sales and profit from its protein-based Covid vaccine,...
Who should get the new COVID vaccines? What to know about the 2023-2024 shots
Live Science via Yahoo News· 8 months agoA syringe is filled with Pfizer-BioNTech Covid-19 vaccine by a woman in blue surgical gloves. Like...
Novavax cuts full-year revenue forecast again amid weak demand
Reuters via Yahoo Finance· 1 year agoThe company now expects annual revenue to be near the low end of its prior forecast range of between...